Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Santaris (Horsholm, Denmark) and GlaxoSmithKline (LSE:GSK; GSK) partnered to discover, develop and commercialize RNA antagonists as antivirals. Santaris will be
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury